메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 107-114

Comparisons of statistical methods in analyzing clinical data through systematically using historical data

Author keywords

re sampling with replacement; statistical power; Systematically using historical data; type I error

Indexed keywords


EID: 84860593558     PISSN: 15741699     EISSN: None     Source Type: Journal    
DOI: 10.3233/MAS-2011-0217     Document Type: Article
Times cited : (1)

References (10)
  • 1
    • 21544472890 scopus 로고    scopus 로고
    • Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy
    • M.C. Carr, R.H. Knopp, J.D. Brunzell, B.S.Wheeler, X. Zhu, A. Lakshmanan, A. Rosen and P.W.Anderson, Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy, Diabetes Care 28 (2005), 1555-1561.
    • (2005) Diabetes Care , vol.28 , pp. 1555-1561
    • M.C. Carr1    R.H. Knopp2    J.D. Brunzell3    B.S. Wheeler4    X. Zhu5    A. Lakshmanan6    A. Rosen7    P.W. Anderson8
  • 2
    • 0036511471 scopus 로고    scopus 로고
    • Fenofibrate lowers plasma triglycerides and increases ldl particle diameter in subjects with type 2 diabetes
    • J. Vakkilainen, G. Steiner, J.-C. Ansquer et al., Fenofibrate Lowers Plasma Triglycerides and Increases LDL Particle Diameter in Subjects With Type 2 Diabetes, Diabetes Care 25 (2002), 627-628.
    • (2002) Diabetes Care , vol.25 , pp. 627-628
    • J. Vakkilainen1    G. Steiner2    J.-C. Ansquer3
  • 3
    • 15944392288 scopus 로고    scopus 로고
    • Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes
    • J. van Wijk, E.J.P. de Koning, M.C. Cabezas and T.J. Rabelink, Rosiglitazone Improves Postprandial Triglyceride and Free Fatty Acid Metabolism in Type 2 Diabetes, Diabetes Care 28 (2006), 844-849.
    • (2006) Diabetes Care , vol.28 , pp. 844-849
    • J. Van Wijk1    E.J.P. De Koning2    M.C. Cabezas3    T.J. Rabelink4
  • 4
    • 0346258216 scopus 로고    scopus 로고
    • Proper metrics for clinical trials: Transformations and other procedures to remove non-normality effects
    • P. Lachenbruch, Proper metrics for clinical trials: transformations and other procedures to remove non-normality effects, Statistics in Medicine 22 (2003), 3823-3842.
    • (2003) Statistics in Medicine , vol.22 , pp. 3823-3842
    • P. Lachenbruch1
  • 5
    • 33744480524 scopus 로고    scopus 로고
    • The loss in power when the test of differential expression is performed under a wrong scale
    • S. Huang and Y. Qu, The loss in power when the test of differential expression is performed under a wrong scale, Journal of Computational Biology 13 (2006), 786-797.
    • (2006) Journal of Computational Biology , vol.13 , pp. 786-797
    • Huang, S.1    Qu, Y.2
  • 6
    • 3142543163 scopus 로고    scopus 로고
    • The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study
    • A. Vickers, The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study, BMC Medical Research Methodology 1(6) (2001).
    • (2001) BMC Medical Research Methodology , vol.1 , pp. 6
    • A. Vickers1
  • 7
    • 0031429893 scopus 로고    scopus 로고
    • Power comparison of non-parametric tests: Small-sample properties from Monte Carlo experiments
    • H. Tanizaki, Power comparison of non-parametric tests: Small-sample properties from Monte Carlo experiments, Journal of Applied Statistics 24 (1997), 603-632.
    • (1997) Journal of Applied Statistics , vol.24 , pp. 603-632
    • H. Tanizaki1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.